Moderna’s CEO Stéphane Bancel spoke at the Boston College Chief Executives Club on April 5. While COVID-19 vaccine production was a big talking point for the leader of Moderna, he also touched on how mRNA technology can usher us into a longer life span, saying that he tells all of his friends to “not die” in the next ten years.
Research Roundup: Link Between Herpes Simplex Virus and Neurogenerative Diseases Gets More Support
Alzheimer’s disease, Clinical Trials, COVID-19 booster shots, Dementia, Herpes Simplex Virus, Medical Journals, Molecules, Multiple Sclerosis, Myelin, Nature Communications, Neurogenerative diseases, Peptides, Proteins, R&D, Rice University, The Lancet, University of Houston, University of Illinois at ChicagoResearchers at the University of Illinois at Chicago published what they are calling a “first of its kind study” that found a possible direct link between neurodegenerative diseases and the herpesvirus.
Research Roundup: Major Breakthrough in HIV Research and More
Australia, China, Coronavirus Disease 2019 (COVID-19), Drug Cocktails, Genes, Genetic Markers, Genomes, Germany, Herpes Simplex Virus, HIV, Immune Cells, Medical Journals, Mount Sinai, Neurodegenerative Diseases, New England Journal of Medicine, Nucleotides, R&D, RNA, San Francisco (UCSF), Science, Scientific studies, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Netherlands, Thrombosis Research, University of Alabama at Birmingham (UAB), University of Maryland Baltimore County, Walter and Eliza Hall InstituteA review of some recently published scientific studies, including researchers at the University of Maryland Baltimore County identifying a single nucleotide that controls two forms of the HIV virus’ RNA.
International Team Develops Promising Broad-Spectrum Antiviral Compound
Antivirals, Biotech, Cyclodextrins, Hepatitis, Herpes Simplex Virus, HIV, HIV Virus, Molecules, Mutations, R&D, Respiratory Syncytial Virus (RSV) Infection, Science Advances, University of Geneva (UNIGE), University of Manchester, Viruses, Zika VirusAn international team of researchers led by the University of Manchester developed a new antiviral using natural glucose derivatives called cyclodextrins – a type of sugar – which shows promise in treating a broad range of viruses including herpes simplex, respiratory syncytial virus, hepatitis C, HIV and Zika virus.